Drugs of abuse: anatomy, pharmacology and function of reward pathways
- PMID: 1604710
- DOI: 10.1016/0165-6147(92)90060-j
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Similar articles
-
Neural mechanisms of drug reinforcement.Ann N Y Acad Sci. 1992 Jun 28;654:171-91. doi: 10.1111/j.1749-6632.1992.tb25966.x. Ann N Y Acad Sci. 1992. PMID: 1632582 Review.
-
The tail of the ventral tegmental area in behavioral processes and in the effect of psychostimulants and drugs of abuse.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):30-38. doi: 10.1016/j.pnpbp.2018.02.002. Epub 2018 Feb 5. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29421265 Review.
-
Action of drugs of abuse on brain reward systems: an update with specific attention to opiates.Pharmacol Biochem Behav. 1982 Aug;17(2):239-43. doi: 10.1016/0091-3057(82)90076-4. Pharmacol Biochem Behav. 1982. PMID: 6127721
-
Brain dopamine and reward.Annu Rev Psychol. 1989;40:191-225. doi: 10.1146/annurev.ps.40.020189.001203. Annu Rev Psychol. 1989. PMID: 2648975 Review.
-
Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies.Behav Brain Res. 1999 Jun;101(2):129-52. doi: 10.1016/s0166-4328(99)00022-4. Behav Brain Res. 1999. PMID: 10372570 Review.
Cited by
-
Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking.Pharmacol Biochem Behav. 2021 Jul;206:173194. doi: 10.1016/j.pbb.2021.173194. Epub 2021 May 1. Pharmacol Biochem Behav. 2021. PMID: 33940055 Free PMC article. Review.
-
Positive allosteric modulation of the GABA(B) receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization.Alcohol. 2012 Aug;46(5):455-62. doi: 10.1016/j.alcohol.2012.03.004. Epub 2012 May 2. Alcohol. 2012. PMID: 22560291 Free PMC article.
-
Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice.J Neurosci. 2005 Mar 2;25(9):2255-66. doi: 10.1523/JNEUROSCI.4372-04.2005. J Neurosci. 2005. PMID: 15745951 Free PMC article.
-
Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders.CNS Neurosci Ther. 2010 Jun;16(3):137-62. doi: 10.1111/j.1755-5949.2010.00142.x. Epub 2010 Mar 29. CNS Neurosci Ther. 2010. PMID: 20370804 Free PMC article. Review.
-
Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.Psychopharmacology (Berl). 2005 Nov;182(4):516-26. doi: 10.1007/s00213-005-0121-5. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16075286 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical